NOUGUES MAXIMO F 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jul 10, 2025
Insider Transaction Report
Form 4
NOUGUES MAXIMO F
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-07-08$3.53/sh−5,587$19,739→ 208,164 total - Sale
Common Stock
2025-07-09$3.54/sh−3,935$13,910→ 204,229 total
Footnotes (1)
- [F1]Adoption date of referenced 10b5-1(c) plan is: 12-14-2020